Status and phase
Conditions
Treatments
About
The purpose of this study is to investigate the efficacy and safety of NT 201 injections in the treatment of enlarged pores and excessive sebum production in the face.
Full description
Eligible subjects will be randomized to one of the two treatment groups: NT 201 group and placebo in order to receive one session of injections with either NT 201 or placebo in the upper face (forehead and cheek area) on Day 1 and followed for about 90 days after treatment.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
31 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
Public Disclosure Manager Merz Aesthetics
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal